Showing results (21-30 of 77) with videos related to
Sort By:
Pageof 8
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 7, 2015
Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, SpainManel Mata-Cases, Marc Casajuana, Josep Franch-Nadal, et al.Endocrinologia, Diabetes Y Nutricion|March 8, 2022
Compliance with the DPP-4 inhibitors dose adjustment recommendations based on renal function in a population databaseJosep Franch-Nadal, Jordi Real Gatius, Manel Mata-Cases, et al.Diabetes, Obesity & Metabolism|February 14, 2019
Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non-insulin antidiabetic drugs in a real-world settingSilvia Canivell, Manel Mata-Cases, Jordi Real, et al.International Journal of Endocrinology|October 21, 2014
Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl StudyJosep Franch-Nadal, Manel Mata-Cases, Irene Vinagre, et al.Frontiers in Endocrinology|December 19, 2022
Obesity and related comorbidities in a large population-based cohort of subjects with type 1 diabetes in CataloniaIdoia Genua, Josep Franch-Nadal, Elena Navas, et al.Frontiers in Cardiovascular Medicine|October 2, 2024
First manifestation of cardiovascular disease according to age and sex in a Mediterranean countryEmilio Ortega, Idoia Genua, Manel Mata-Cases, et al.Diabetes Research and Clinical Practice|August 7, 2022
Comorbid autoimmune diseases and burden of diabetes-related complications in patients with type 1 diabetes from a Mediterranean areaGabriel Gimenez-Perez, Bogdan Vlacho, Elena Navas, et al.Family Practice|September 7, 2014
Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes durationJosep Franch-Nadal, Pilar Roura-Olmeda, Belén Benito-Badorrey, et al.Journal of Clinical Medicine|September 8, 2019
Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes: Prescription According to Reimbursement Constraints and Guideline Recommendations in CataloniaJosep Franch-Nadal, Manel Mata-Cases, Emilio Ortega, et al.Primary Care Diabetes|July 16, 2011
Trends in chronic complications of type 2 diabetic patients from Spanish primary health care centres (GEDAPS study): ten year-implementation of St. Vincent recommendationsXavier Mundet, Francisco Cano, Manel Mata-Cases, et al.Pageof 8